Hepatitis C virus (HCV)-specific in vitro antibody secretion by peripheral blood lymphocytes: correlation with progression of disease and HCV RNA in HCV antibody-positive patients

J Clin Microbiol. 1994 Oct;32(10):2613-5. doi: 10.1128/jcm.32.10.2613-2615.1994.

Abstract

Hepatitis C virus-specific in vitro antibody production (HCV IVAP) by peripheral blood lymphocytes in 53 HCV antibody-positive patients was investigated in comparison with alanine aminotransferase (ALT) levels and HCV RNA in serum samples. All 29 HCV IVAP-positive patients were HCV RNA positive; 26 had elevated ALT levels. Among the 24 HCV IVAP-negative patients, 16 were HCV RNA negative, with 12 presenting normal ALT values. These data indicate that HCV IVAP results are highly correlated (P < 0.001) with HCV RNA results and ALT levels. Our study indicates that HCV IVAP can be used as a novel assay in the diagnosis and pathogenesis exploration of HCV infection.

MeSH terms

  • Adult
  • Aged
  • Alanine Transaminase / blood
  • Cells, Cultured
  • Female
  • Hepacivirus / genetics
  • Hepacivirus / immunology*
  • Hepatitis Antibodies / analysis*
  • Hepatitis Antibodies / biosynthesis
  • Hepatitis C / diagnosis*
  • Hepatitis C Antibodies
  • Humans
  • Lymphocytes / immunology*
  • Male
  • Middle Aged
  • RNA, Viral / analysis*

Substances

  • Hepatitis Antibodies
  • Hepatitis C Antibodies
  • RNA, Viral
  • Alanine Transaminase